157 related articles for article (PubMed ID: 35945083)
21. [Stereotactic body radiotherapy as "first-line treatment" for oligometastatic renal cell cancer].
Guckenberger M
Strahlenther Onkol; 2022 May; 198(5):497-499. PubMed ID: 35278095
[No Abstract] [Full Text] [Related]
22. [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist].
Müller AC; van Oorschot B; Micke O; Guckenberger M
Strahlenther Onkol; 2018 Jan; 194(1):1-8. PubMed ID: 28819766
[TBL] [Abstract][Full Text] [Related]
23. Current Role of Radiotherapy for Renal-Cell Carcinoma: Review.
Dengina N; Tsimafeyeu I; Mitin T
Clin Genitourin Cancer; 2017 Apr; 15(2):183-187. PubMed ID: 27789182
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic Ablative Radiotherapy as a Tool in Renal Cell Carcinoma for Building RAPPORT with Systemic Therapy.
Mercier C; Strijbos M; Ost P
Eur Urol; 2022 Apr; 81(4):373-374. PubMed ID: 35063309
[No Abstract] [Full Text] [Related]
25. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
Miccio JA; Oladeru OT; Jun Ma S; Johung KL
Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiation therapy (SBRT): A new treatment option in renal cancer.
Couñago F; López-Campos F
Actas Urol Esp (Engl Ed); 2024 May; 48(4):260-261. PubMed ID: 37984716
[No Abstract] [Full Text] [Related]
27. Editorial Comment: The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Zequi SC
Int Braz J Urol; 2020; 46(3):473. PubMed ID: 32167721
[No Abstract] [Full Text] [Related]
28. Durable control of locally recurrent renal cell carcinoma using stereotactic body radiotherapy.
Maclean J; Breau RH; Scheida N; Malone S
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25199199
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic ultrasound-guided placement of fiducial markers for stereotactic body radiation therapy of pancreatic metastases from renal cell carcinoma.
Polkowski M; Pawlewicz K; Skoczylas K; Wrońska E; Lenarcik M; Reguła J
Endoscopy; 2023 Dec; 55(S 01):E876-E877. PubMed ID: 37442168
[No Abstract] [Full Text] [Related]
30. Radiotherapy for renal-cell carcinoma.
De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
[TBL] [Abstract][Full Text] [Related]
31. Novel case of nephrocolic fistula secondary to stereotactic ablative body radiotherapy for clear cell renal cell carcinoma.
Brinded A; Tay YK; Woods R
ANZ J Surg; 2020 Sep; 90(9):1800-1801. PubMed ID: 31989764
[No Abstract] [Full Text] [Related]
32. Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: combination of stereotactic ablative body radiotherapy and radical nephrectomy for synchronous bilateral primary renal cell carcinoma.
Ali M; Gaudreault M; Siva S
BJU Int; 2023 May; 131(5):562-565. PubMed ID: 36716731
[No Abstract] [Full Text] [Related]
33. Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function.
Senger C; Conti A; Kluge A; Pasemann D; Kufeld M; Acker G; Lukas M; Grün A; Kalinauskaite G; Budach V; Waiser J; Stromberger C
BMC Urol; 2019 Oct; 19(1):96. PubMed ID: 31638979
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
35. Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: a case report.
Hilleary LA; Wratten C; Siva S; Hilleary J; Martin JM
BMC Cancer; 2019 Jul; 19(1):671. PubMed ID: 31286870
[TBL] [Abstract][Full Text] [Related]
36. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
Miccio J; Johung K
Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
[TBL] [Abstract][Full Text] [Related]
37. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).
Siva S; Louie AV; Warner A; Muacevic A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh B; Correa RJ; Lo SS; Staehler M
Cancer; 2018 Mar; 124(5):934-942. PubMed ID: 29266183
[TBL] [Abstract][Full Text] [Related]
38. Preoperative stereotactic body radiotherapy combined with surgical treatment for renal cell carcinoma and inferior vena cava tumour thrombus: study protocol for a single-arm cohort trial.
Liu Y; Liu Z; Peng R; Xiao R; Wang J; Wang H; Ma L
BMJ Open; 2022 Jan; 12(1):e055364. PubMed ID: 35105644
[TBL] [Abstract][Full Text] [Related]
39. Technique for stereotactic body radiotherapy for spinal metastases.
Foote M; Letourneau D; Hyde D; Massicotte E; Rampersaud R; Fehlings M; Fisher C; Lewis S; Macchia NL; Yu E; Laperriere NJ; Sahgal A
J Clin Neurosci; 2011 Feb; 18(2):276-9. PubMed ID: 21147535
[TBL] [Abstract][Full Text] [Related]
40. [A systematic review of radiotherapy for primary renal cell carcinoma].
Gladilina IA; Shabanov MA; Kushlinskii NE; Bliganov PI; Sergeev AN
Urologiia; 2022 Mar; (1):96-101. PubMed ID: 35274868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
